Partner Spotlight: SparingVision

We’re proud to highlight our collaboration with SparingVision, a clinical-stage genomic medicines company revolutionizing treatments for inherited retinal diseases, including Retinis Pigmentosa. Their mission is to harness the potential of gene therapy and genome editing to bring cutting-edge innovation into ocular disease drug discovery and development.

SparingVision brings together over 20 years of world-class ophthalmology research with a seasoned team of experts from across the global drug development ecosystem.

Here’s what Gaëlle FANON, PharmD, Quality Assurance Director of SparingVision, shared about working with INITS:

“INITS is a trusted Quality Assurance partner that SparingVision has been successfully working with for more than 3 years.

Amel and her team are very responsive and provide us with high quality GMP support and skills, solution-oriented and tailored to our needs as a clinical-stage biotech. INITS support us for the conduct of GMP audits and trainings, the setup and lifecycle of our Quality Management System, the review of operational documents and recommendations on challenging ad hoc questions”

A sincere thank you to the SparingVision team for their trust and collaboration. We look forward to continuing this inspiring journey together!"

#Partnership #Biotechnology #GenomicMedicine #GeneTherapy #Ophthalmology #QualityAssurance  #CMC #RegulatoryAffairs #Innovation #Biopharma